BATF2 and COVID-19: A recent study in COVID-19 host genetics found that BATF2 controls the production of cytokines from CD4+ T-cells and macrophages in mice [69] and participates in interferon signaling [70], highlighting a potential immunotherapeutic target to mitigate COVID-19.